fujianmycin B: the isomer SNA-8073-B inhibits prolyl endopeptidase; from Streptomyces; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 126038 |
| MeSH ID | M0132762 |
| Synonym |
|---|
| fujianmycin b |
| 96695-58-8 |
| sna 8073-b |
| sna 8073a |
| rubiginone a2 |
| sna 8073-a |
| sna-8073-b |
| sna-8073-a |
| rubiginone a2 |
| 130548-09-3 |
| ribiginone a(2) |
| benz(a)anthracene-1,7,12(2h)-trione, 3,4-dihydro-4-hydroxy-8-methoxy-3-methyl-, trans-(+)- |
| HB4061 |
| DTXSID30914388 |
| 4-hydroxy-8-methoxy-3-methyl-3,4-dihydrotetraphene-1,7,12(2h)-trione |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.41) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||